Author

Chang-Heok Soh

Observed institutions: Harvard University, Alnylam Pharmaceuticals (United States), Queen Mary University of London, Genentech, King's College London, Guy's and St Thomas' NHS Foundation Trust, The Royal Free Hospital, Tan Tock Seng Hospital, AbbVie (United States)

OpenAlex ID: A5110175311

Works count: 14

Citation count: 1,077

H-index: 8

I10-index: 8